drugset / Trial / NCT01285115

The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form

NCT01285115 ↗

Phase 3 Completed 147 enrolled Korea Health Industry Development Institute
RandomizedParallel-groupTriple-blindTreatment

Summary

In this randomized, double blinded, Parallel-controlled study, the investigators planned to give Gamisoyosan extract, Gamisoyosan extract powder or controlled medication on Anxiety of generalized anxiety disorder according to dosage form.

Timeline

Start
2008-12
Primary completion
2010-06
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator KyungBangn Gamisoyosan Unknown 7.67 g —
Comparator KyungBangn-Gamisoyosan-x-gwarip Unknown 7.67 g —